Thomas Nogueira Vilches, Cláudia Pio Ferreira, Miguel Rubira Telles, Lais Moraes Paiz, Gabriel Berg de Almeida
{"title":"Dengue virus introduction and 2025 outlook: scenario-based evaluation of vaccination impact using mathematical modeling.","authors":"Thomas Nogueira Vilches, Cláudia Pio Ferreira, Miguel Rubira Telles, Lais Moraes Paiz, Gabriel Berg de Almeida","doi":"10.1590/0102-311XEN150325","DOIUrl":null,"url":null,"abstract":"<p><p>This study aims to model multiple scenarios of dengue introduction and spread in Botucatu, São Paulo State, Brazil, and to evaluate the impact of vaccination strategies on the epidemic trajectory in a city that, until 2023, had less than 1% of its population infected with dengue. First, we estimated the basic reproduction number (R 0 ) during the 2024 epidemic and compared it with values reported in the literature. We then developed an age-stratified mathematical model, calibrated to 2024 dengue case data using a genetic algorithm, to simulate transmission dynamics with and without vaccination. This approach enabled us to assess the potential reduction in infections under various immunization scenarios. The estimated R 0 for the 2024 epidemic was 1.57, resulting in an attack rate exceeding 10% of the population. Our model accurately fits the observed data and suggests that, under conditions similar to those of 2024, the introduction of a new serotype in 2025 would likely trigger another epidemic. Vaccination could reduce this peak by up to 80%, depending on coverage among individuals aged 10-14 years. The results indicate that the R 0 of dengue estimated for Botucatu in 2024 is consistent with values reported for other Brazilian cities. The vaccination campaign shows the potential to reduce dengue cases by 75% or more. However, since campaign effectiveness depends on the circulating serotype and the epidemiological status of vaccinated individuals, achieving vaccination coverage above 50% in the target population is essential to avoid the need for individual epidemiological screening.</p>","PeriodicalId":9398,"journal":{"name":"Cadernos de saude publica","volume":"42 ","pages":"e00150325"},"PeriodicalIF":2.1000,"publicationDate":"2026-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13313151/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cadernos de saude publica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1590/0102-311XEN150325","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
This study aims to model multiple scenarios of dengue introduction and spread in Botucatu, São Paulo State, Brazil, and to evaluate the impact of vaccination strategies on the epidemic trajectory in a city that, until 2023, had less than 1% of its population infected with dengue. First, we estimated the basic reproduction number (R 0 ) during the 2024 epidemic and compared it with values reported in the literature. We then developed an age-stratified mathematical model, calibrated to 2024 dengue case data using a genetic algorithm, to simulate transmission dynamics with and without vaccination. This approach enabled us to assess the potential reduction in infections under various immunization scenarios. The estimated R 0 for the 2024 epidemic was 1.57, resulting in an attack rate exceeding 10% of the population. Our model accurately fits the observed data and suggests that, under conditions similar to those of 2024, the introduction of a new serotype in 2025 would likely trigger another epidemic. Vaccination could reduce this peak by up to 80%, depending on coverage among individuals aged 10-14 years. The results indicate that the R 0 of dengue estimated for Botucatu in 2024 is consistent with values reported for other Brazilian cities. The vaccination campaign shows the potential to reduce dengue cases by 75% or more. However, since campaign effectiveness depends on the circulating serotype and the epidemiological status of vaccinated individuals, achieving vaccination coverage above 50% in the target population is essential to avoid the need for individual epidemiological screening.
期刊介绍:
Cadernos de Saúde Pública/Reports in Public Health (CSP) is a monthly journal published by the Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation (ENSP/FIOCRUZ).
The journal is devoted to the publication of scientific articles focusing on the production of knowledge in Public Health. CSP also aims to foster critical reflection and debate on current themes related to public policies and factors that impact populations'' living conditions and health care.
All articles submitted to CSP are judiciously evaluated by the Editorial Board, composed of the Editors-in-Chief and Associate Editors, respecting the diversity of approaches, objects, and methods of the different disciplines characterizing the field of Public Health. Originality, relevance, and methodological rigor are the principal characteristics considered in the editorial evaluation. The article evaluation system practiced by CSP consists of two stages.